EX-99.1 2 q413coherentearningsreleas.htm 8-K EXHIBIT Q413CoherentEarningsRelease_EXHIBIT



Exhibit 99.1


@coherent
 
PRESS RELEASE
Editorial Contact:
 
For Release:
Leen Simonet
 
IMMEDIATE
(408) 764-4110
 
October 30, 2013
 
 
No. 1372


Coherent, Inc. Reports Fourth Fiscal Quarter and Year-End Results

SANTA CLARA, CA, October 30, 2013 -- Coherent, Inc. (NASDAQ, COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its fourth fiscal quarter and fiscal year ended September 28, 2013.

FINANCIAL HIGHLIGHTS

 
Three Months Ended

Year Ended
 
Sept. 28, 2013

June 29, 2013

Sept. 29, 2012

Sept. 28, 2013

Sept. 29, 2012
GAAP Results
 
 
 
 
 
 
 
 
 
(in millions except per share data)
 
 
 
 
 
 
 
 
Bookings
$200.3
 
$189.2
 
$169.3
 
$767.3
 
$773.2
Net sales
$213.1
 
$213.7
 
$188.7
 
$810.1
 
$769.1
Net income
$20.5
 
$16.7
 
$12.5
 
$66.4
 
$63.0
Diluted EPS
$0.83
 
$0.68
 
$0.52
 
$2.70
 
$2.62
 
 
 
 
 
 
 
 
 
 
Non-GAAP Results
 
 
 
 
 
 
 
 
 
(in millions except per share data)
 
 
 
 
 
 
 
 
Net income
$25.6
 
$22.6
 
$18.1
 
$87.4
 
$78.8
Diluted EPS
$1.03
 
$0.91
 
$0.75
 
$3.56
 
$3.28


FOURTH FISCAL QUARTER DETAILS

For the fourth fiscal quarter ended September 28, 2013, Coherent announced net sales of $213.1 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $20.5 million, or $0.83 per diluted share. These results compare to net sales of $188.7 million and net income of $12.5 million, or $0.52 per diluted share, for the fourth quarter of fiscal 2012. Coherent’s results for the fourth quarter of fiscal 2012 includes a charge of approximately $4.3 million after tax due to the write-off of previously acquired intangible assets and inventories and a tax benefit of approximately $2.8 million due to the release of tax valuation allowances.

Non-GAAP net income for the fourth quarter of fiscal 2013 was $25.6 million, or $1.03 per diluted share. Non-GAAP net income for the fourth quarter of fiscal 2012 was $18.1 million, or $0.75 per diluted share. Beginning in the second quarter of fiscal 2013, the company revised its presentation of non-GAAP net income and non-GAAP diluted EPS for all periods presented to exclude the effect of intangibles amortization and inventory step up costs. For a complete overview of the differences between GAAP and non-GAAP results, please see the reconciliation table included at the end of this release.





Exhibit 99.1


Net sales for the third quarter of fiscal 2013 were $213.7 million and net income, on a GAAP basis, was $16.7 million, or $0.68 per diluted share. Non-GAAP net income for the third quarter of fiscal 2013 was $22.6 million, or $0.91 per diluted share.

Bookings received during the fourth fiscal quarter ended September 28, 2013 of $200.3 million increased 18.3% from $169.3 million in the same prior year period and increased by 5.9% compared to bookings of $189.2 million in the immediately preceding quarter. The book-to-bill ratio was 0.94, and ending backlog shipping in the next 12 months was $285.8 million at September 28, 2013, compared to a backlog of $299.2 million at June 29, 2013 and a backlog of $352.8 million at September 29, 2012.

For the fiscal year ended September 28, 2013, Coherent posted net sales of $810.1 million and net profit of $66.4 million ($2.70 per diluted share) on a GAAP basis compared to the prior year sales of $769.1 million and a net profit on a GAAP basis of $63.0 million ($2.62 per diluted share). Bookings received for the fiscal year ended September 28, 2013 were $767.3 million, compared to $773.2 million in bookings received during fiscal 2012.

“We posted a very strong performance in our fourth fiscal quarter including record service revenues and cash generation.  We received the first tranche of new ELA orders (>$15 million) and the ELA order pipeline for fiscal 2014 looks robust.  There was marked demand improvement within the semiconductor capital equipment industry tied to the introduction of new wafer inspection tools.  Ophthalmic and emerging dental applications coupled with increased adoption of our OBIS™ platform led to very solid orders in the instrumentation and OEM component market,” said John Ambroseo, Coherent’s President and Chief Executive Officer.  “Record annual orders from Asia (excluding Japan) as well as a strong quarter in the U.S. fueled a recovery of research orders.  And while materials processing bookings were seasonally lower, we ended the fiscal year with a new materials processing bookings record,” Ambroseo said.

Coherent ended the quarter with cash, cash equivalents and short term investments of $250.1 million, an increase of $48.4 million from cash, cash equivalents and short term investments of $201.7 million at June 29, 2013.

CONFERENCE CALL REMINDER

The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company's website at either http://www.coherent.com/Investors/ or http://www.earnings.com. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on both web sites. A transcript of management’s prepared remarks can be found at http://www.coherent.com/Investors/.





Exhibit 99.1


Summarized statement of operations information is as follows (unaudited, in thousands except per share data):

 
 
Three Months Ended
 
Year Ended
 
 
Sept. 28, 2013

June 29, 2013

Sept. 29, 2012

Sept. 28, 2013

Sept. 29, 2012
 
 
 
 
 
 
 
 
 
 
 
Net Sales
$
213,141

$
213,725

$
188,654

$
810,126

$
769,088

Cost of sales(A)(B)(C)(D) 
 
128,100

 
130,461

 
110,921

 
487,855

 
453,103

Gross profit
 
85,041

 
83,264

 
77,733

 
322,271

 
315,985

Operating expenses:
 


 


 


 


 


Research & development(A)(B) 
 
21,556

 
21,782

 
19,852

 
82,785

 
78,260

Selling, general & administrative(A)(B) 
 
36,437

 
38,748

 
35,617

 
149,513

 
138,519

Intangibles amortization(C) 
 
988

 
1,290

 
5,406

 
5,074

 
10,376

Total operating expenses
 
58,981

 
61,820

 
60,875

 
237,372

 
227,155

Income from operations
 
26,060

 
21,444

 
16,858

 
84,899

 
88,830

Other income (expense), net(B)
 
(308
)
 
(953
)
 
1,299

 
(1,403
)
 
1,792

Income before income taxes
 
25,752

 
20,491

 
18,157

 
83,496

 
90,622

Provision for income taxes(E) 
 
5,237

 
3,806

 
5,609

 
17,141

 
27,660

Net income
$
20,515

$
16,685

$
12,548

$
66,355

$
62,962

 
 


 


 


 


 


Net income per share:
 


 


 


 


 


Basic
$
0.84

$
0.69

$
0.53

$
2.75

$
2.67

Diluted
$
0.83

$
0.68

$
0.52

$
2.70

$
2.62

 
 


 


 


 


 


Shares used in computations:
 


 


 


 


 


Basic
 
24,385

 
24,310

 
23,629

 
24,138

 
23,561

Diluted
 
24,836

 
24,690

 
24,095

 
24,555

 
24,026



(A)
Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data):

Stock-related compensation expense
 
Three Months Ended
 
Year Ended
 
 
Sept. 28, 2013

June 29, 2013

Sept. 29, 2012

Sept. 28, 2013

Sept. 29, 2012
Cost of sales
$
546

$
576

$
407

$
2,151

$
1,670

Research & development
 
454

 
455

 
397

 
1,852

 
1,628

Selling, general & administrative
 
3,615

 
3,610

 
3,201

 
14,889

 
13,015

Impact on income from operations
$
4,615

$
4,641

$
4,005

$
18,892

$
16,313


For the quarters ended September 28, 2013, June 29, 2013, and September 29, 2012, the impact on net income, net of tax was $3,146 ($0.13 per diluted share), $3,446 ($0.14 per diluted share) and $3,076 ($0.13 per diluted share), respectively. For the year ended September 28, 2013 and September 29, 2012, the impact on net income, net of tax was $13,600 ($0.55 per diluted share) and $11,517 ($0.48 per diluted share), respectively.





Exhibit 99.1


(B)
Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net. Deferred compensation expense (benefit) included in operating results is summarized below:

Deferred compensation expense (benefit)
 
Three Months Ended
 
Year Ended
 
 
Sept. 28, 2013

June 29, 2013

Sept. 29, 2012

Sept. 28, 2013

Sept. 29, 2012
Cost of sales
$
3

$
35

$
34

$
89

$
59

Research & development
 
3

 
159

 
154

 
373

 
293

Selling, general & administrative
 
(22
)
 
841

 
1,028

 
2,311

 
1,972

Impact on income from operations
$
(16
)
$
1,035

$
1,216

$
2,773

$
2,324


For the quarters ended September 28, 2013, June 29, 2013, and September 29, 2012, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was expense of $163, income of $1,010 and income of $1,207, respectively. For the years ended September 28, 2013 and September 29, 2012, the impact on other income (expense) net was income of $2,123 and income of $1,643, respectively.

(C)
For the quarters ended September 28, 2013, June 29, 2013, and September 29, 2012, the impact of amortization of intangibles expense was $2,454 ($1,912 net of tax ($0.08 per diluted share)), $2,724 ($2,194 net of tax ($0.09 per diluted share)) and $1,436 ($1,012 net of tax ($0.04 per diluted share)), respectively. For the year ended September 28, 2013 and September 29, 2012, the impact of amortization of intangibles expense was $9,767 ($7,748 net of tax ($0.32 per diluted share)) and $6,406 ($4,468 net of tax ($0.19 per diluted share)), respectively. The quarter and year ended September 29, 2012 include a $4,260 ($4,260 net of tax ($0.18 per diluted share)) charge due to the write-off of previously acquired intangible assets ($3,970 recorded in intangibles amortization) and inventories ($290 recorded in cost of sales).

(D)
For the quarter ended June 29, 2013, the impact of our inventory step up costs related to our recent acquisitions was $367 ($257 net of tax ($0.01 per diluted share)). For the year ended September 28, 2013, the impact on net income of our inventory step up costs related to our recent acquisitions was $1,589 ($1,112 net of tax ($0.05 per diluted share)).

(E)
The year ended September 28, 2013 included $1,398 ($0.06 per diluted share) benefit from the renewal of the R&D tax credit for fiscal 2012. The quarter and year ended September 29, 2012 include a $2,790 ($0.12 per diluted share) benefit due to decreases in valuation allowances against deferred tax assets. The year ended September 29, 2012 includes $1,647 ($0.07 per diluted share) release of tax reserves and related interest as a result of the closure of open tax years.





Exhibit 99.1



Summarized balance sheet information is as follows (unaudited, in thousands):

 
 
Sept. 28, 2013
 
Sept. 29, 2012
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash, cash equivalents and short-term investments
$
250,110

$
224,929

Accounts receivable, net
 
136,759

 
144,345

Inventories
 
168,067

 
160,113

Prepaid expenses and other assets
 
74,290

 
85,098

Total current assets
 
629,226

 
614,485

Property and equipment, net
 
114,333

 
115,096

Other assets
 
222,919

 
151,191

Total assets
$
966,478

$
880,772

 
 


 


LIABILITIES AND STOCKHOLDERS' EQUITY
 


 


Current liabilities:
 


 


Current portion of long-term obligations
$
2

$
17

Accounts payable
 
36,565

 
29,088

Other current liabilities
 
109,261

 
124,683

Total current liabilities
 
145,828

 
153,788

Other long-term liabilities
 
62,132

 
55,328

Total stockholders’ equity
 
758,518

 
671,656

Total liabilities and stockholders’ equity
$
966,478

$
880,772



Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):

 
 
Three Months Ended
 
Year Ended
 
 
Sept. 28, 2013
 
June 29, 2013
 
Sept. 29, 2012
 
Sept. 28, 2013

Sept. 29, 2012
GAAP net income
$
20,515

$
16,685

$
12,548

$
66,355

$
62,962

Stock-related compensation expense
 
3,146

 
3,446

 
3,076

 
13,600

 
11,517

Write-off of intangibles and inventory
 
—

 
—

 
4,260

 
—

 
4,260

Intangibles amortization
 
1,912

 
2,194

 
1,012

 
7,748

 
4,468

Inventory step-up
 
—

 
257

 
—

 
1,112

 
—

Non-recurring tax expense (release) items
 
—

 
—

 
(2,790
)
 
(1,398
)
 
(4,437
)
Non-GAAP net income
$
25,573

$
22,582

$
18,106

$
87,417

$
78,770

 
 
 
 
 
 
 
 
 
 
 
Non-GAAP net income per diluted share
$
1.03

$
0.91

$
0.75

$
3.56

$
3.28













Exhibit 99.1



FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to any timing for or occurrence of orders for the Company’s ELA products. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement.  Factors that could cause actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with any general market recovery, growth in demand for our products, growth in demand for the Company's ELA products, the worldwide demand for flat panel displays, the demand for and use of short-pulse lasers in commercial applications, our successful implementation of our customer design wins,  our and our customers’ exposure to risks associated with worldwide economic conditions and, the ability of our customers to forecast their own end markets, our ability to accurately forecast future periods, customer acceptance and adoption of our new product offerings, continued timely availability of products and materials from our suppliers, our ability to timely ship our products and our customers’ ability to accept such shipments, our ability to have our customers qualify our product offerings, worldwide government economic policies and other risks identified in the Company’s SEC filings.  Readers are encouraged to refer to the risk disclosures and critical accounting policies and estimates described in the Company’s reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company.  Actual results, events and performance may differ materially from those presented herein.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
 
































Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Standard & Poor’s SmallCap 600 Index and the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4110. For more information about Coherent, visit the Company's Web site at http://www.coherent.com/ for product and financial updates.


5100 Patrick Henry Dr. . P. O. Box 54980, Santa Clara, California 95056–0980 . Telephone (408) 764-4000